参考文献

1.Dokoumetzidis, A., Macheras, P. (2006). A century of dissolution research: From Noyes and Whitney to the biopharmaceutics classification system. Int. J. Pharm ., 321, 1–11.

2.Avdeef, A. (2010). Leakiness and size exclusion of paracellular channels in cultured epithelial cell monolayers-interlaboratory comparison. Pharm. Res ., 27, 480–489.

3.Sugano, K. (2009). Introduction to computational oral absorption simulation. Expert Opin.Drug Metabol. Toxicol ., 5, 259–293.

4.Sugano, K., Okazaki, A., Sugimoto, S., Tavornvipas, S., Omura, A., Mano, T. (2007).Solubility and dissolution profile assessment in drug discovery. Drug Metabol.Pharmacokinet ., 22, 225–254.

5.Galia, E., Nicolaides, E., Horter, D., Lobenberg, R., Reppas, C., Dressman, J.B. (1998).Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res ., 15, 698–705.

6.Nawroth, T., Buch, P., Buch, K., Langguth, P., Schweins, R. (2011). Liposome Formation from bile salt-lipid micelles in the digestion and drug delivery model FaSSIF(mod) estimated by combined time-resolved neutron and dynamic light scattering. Mol. Pharm ., 8, 2162–2172.

7.Okazaki, A., Mano, T., Sugano, K. (2007). Theoretical dissolution model of poly disperse drug particles in biorelevant media. J. Pharmaceut. Sci. Tech ., Japan (meeting abstract and poster), 67.

8.Li, C.-Y., Zimmerman, C.L., Wiedmann, T.S. (1996). Diffusivity of bile salt/ phospholipid aggregates in mucin. Pharmceut. Res ., 13, 535–541.

9.Naylor, L.J., Bakatselou, V., Dressman, J.B. (1993). Comparison of the mechanism of dissolution of hydrocortisone in simple and mixed micelle systems. Pharmaceut. Res ., 10,865–870.

10.Balakrishnan, A., Rege, B.D., Amidon, G.L., Polli, J.E. (2004). Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity. J.Pharmaceut. Sci ., 93, 2064–2075.

11.Rao, V.M., Lin, M., Larive, C.K., Southard, M.Z. (1997). A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions. J. Pharmaceut. Sci ., 86,1132–1137.

12.Granero, G.E., Ramachandran, C., Amidon, G.L. (2005). Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev. Ind. Pharmaceut ., 31, 917–922.

13.Sun, W., Larive, C.K., Southard, M.Z. (2003). A mechanistic study of danazol dissolution in ionic surfactant solutions. J. Pharmaceut. Sci ., 92, 424–435.

14.Okazaki, A., Mano, T., Sugano, K. (2008). Theoretical dissolution model of polydisperse drug particles in biorelevant media. J. Pharmaceut. Sci ., 97, 1843–1852.

15.Sugano, K. (2010). Aqueous boundary layers related to oral absorption of a drug: from dissolution of a drug to carrier mediated transport and intestinal wall metabolism. Mol.Pharmaceut ., 7, 1362–1373.

16.Avdeef, A., Tsinman, O. (2008). Miniaturized rotating disk intrinsic dissolution rate measurement: effects of buffer capacity in comparisons to traditional Wood’s apparatus. Pharmaceut. Res ., 25, 2613–2627.

17.Kou, J.H., Fleisher, D., Amidon, G.L. (1991). Calculation of the aqueous diffusion layer resistance for absorption in a tube: application to intestinal membrane permeability determination. Pharmaceut. Res ., 8, 298–305.

18.Camenen, B. (2007). Simple and general formula for the settling velocity of particles. J.Hydraul. Eng ., 133, 229–233.

19.Sugano, K. (2008). Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development. Int. J. Pharmaceut ., 363,73–77.

20.Armenante, P.M., Kirwan, D.J. (1989). Mass transfer to microparticles in agitated systems. Chem. Eng. Sci ., 44, 2781–2796.

21.Crail, D.J., Tunis, A., Dansereau, R. (2004). Is the use of a 200ml vessel suitable for dissolution of low dose drug products? Int. J. Pharmaceut ., 269, 203–209.

22.Harriott, P. (1962). Mass transfer to particles: Part 1. Suspended inagitated tanks. AICHE Journal , 8, 93–102.

23.Galli, C. (2006). Experimental determination of the diffusion boundary layer width of micron and submicron particles. Int. J. Pharmaceut ., 313, 114–122.

24.Shirhatti, V., Wang, M., Williams, R., Ortega, J.R. (2007). Determination of minimum agitation speed for complete solid suspension using four electrode conductivity method. AIP Conf. Proc ., 914, 389–396.

25.Sugano, K. (2011). Fraction of a dose absorbed estimation for structurally diverse low solubility compounds. Int. J. Pharmaceut ., 405, 79–89.

26.Ostergaard, J., Ye, F., Rantanen, J., Yaghmur, A., Larsen, S.W., Larsen, C., Jensen, H. (2011).Monitoring lidocaine single-crystal dissolution by ultraviolet imaging. J. Pharmaceut. Sci .,100, 3405–3410.

27.Hintz, R.J., Johnson, K.C. (1989). The effect of particle size distribution on dissolution rate and oral absorption. Int. J. Pharmaceut ., 51, 9–17.

28.Wang, J., Flanagan, D.R. (2002). General solution for diffusion-controlled dissolution of spherical particles. 2. Evaluation of experimental data. J. Pharmaceut. Sci ., 91, 534–542.

29.Wang, J., Flanagan, D.R. (1999). General solution for diffusion-controlled dissolution of spherical particles. 1. Theory. J. Pharmaceut. Sci ., 88, 731–738.

30.Sugano, K. (2010). Computational oral absorption simulation of free base drugs. Int. J.Pharmaceut .31. Mooney, K.G., Mintun, M.A., Himmelstein, K.J., Stella, V.J. (1981).Dissolution kinetics of carboxylic acids. I: Effect of pH under unbuffered conditions. J.Pharmaceut. Sci ., 70, 13–22.

31.Mooney, K.G., Mintun, M.A., Himmelstein, K.J., Stella, V.J. (1981). Dissolution kinetics of carboxylic acids. II: Effects of buffers. J. Pharmaceut. Sci ., 70, 22–32.

32.Serajuddin, A.T.M., Jarowski, C.I. (1985). Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical bases and their hydrochloride salts. I: Phenazopyridine. J.Pharmaceut. Sci ., 74,142–147.

33.Serajuddin, A.T.M., Jarowski, C.I. (1985). Effect of diffusion layer pH and solubility on the dissolution rate of pharmaceutical acids and their sodium salts. II: Salicylic acid,theophylline, and benzoic acid. J. Pharmaceut. Sci ., 74, 148–154.

34.Sheng, J.J., McNamara, D.P., Amidon, G.L. (2009). Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers. Mol. Pharmaceut ., 6,29–39.

35.Sugano, K. (2009). A simulation of oral absorption using classical nucleation theory. Int. J.Pharmaceut ., 378, 142–145.

36.Liu, X.Y. (1999). A new kinetic model for three-dimensional heterogeneous nucleation. J.Chem. Phys ., 111, 1628–1635.

37.Lindfors, L., Forssen, S., Westergren, J., Olsson, U. (2008). Nucleation and crystal growth in supersaturated solutions of a model drug. J. Colloid Interface Sci ., 325, 404–413. TOP1DBEVz05mlFsBO5rDXg3GG+7iIwd1CM5H3E5o5hjhHRlQpgAtM3WDHdJLng9o